Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71,833,789
-
Total 13F shares
-
33,224,016
-
Share change
-
+1,629,297
-
Total reported value
-
$448,316,000
-
Price per share
-
$13.57
-
Number of holders
-
50
-
Value change
-
+$21,697,973
-
Number of buys
-
20
-
Number of sells
-
20
Institutional Holders of Ventyx Biosciences, Inc. - Common Stock (VTYX) as of Q1 2022
As of 31 Mar 2022,
Ventyx Biosciences, Inc. - Common Stock (VTYX) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,224,016 shares.
The largest 10 holders included
venBio Partners LLC, Third Point LLC, CITADEL ADVISORS LLC, Logos Global Management LP, JANUS HENDERSON GROUP PLC, Vivo Capital, LLC, RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, EcoR1 Capital, LLC, and ORBIMED ADVISORS LLC.
This page lists
50
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.